BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The net proceeds will be used to purchase gold bullion, for working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Offer Details
Shares of common stock being offered through underwritten public offering.
Net Proceeds
Intended use for purchasing gold bullion, working capital, and corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers.
- The completion of the offering is subject to market conditions.
- The offering is made pursuant to a shelf registration statement on Form S-3.
- Investors are advised to read the preliminary prospectus supplement and supporting documents.
BioSig Technologies Inc.'s proposed public offering aims to raise capital for strategic investments and operational needs, showcasing a proactive approach to financial management and expansion.